Ruchita joined Sanofi Ventures in 2016 with a relevant background in digital health. Prior to Sanofi, Ruchita was at GE Ventures, where she invested in and built partnerships with healthcare startups and served as a board observer for several portfolio companies. Ruchita also managed GE’s seed-stage portfolio of digital health investments in partnership with StartUp Health.
Ruchita has more than 15 years of healthcare experience in pharma, biotech, medical devices, and healthcare IT. Prior to GE Ventures, Ruchita was at Pfizer’s Strategy, BD, & Portfolio Management group, and a management consultant with LEK Consulting. Ruchita started her career with Maxygen, an early stage biotech company.
Ruchita is currently a board observer for Inozyme and Omada Health.
Ruchita holds an MBA from the University of Chicago, an MS in Cellular and Molecular Biology from the University of Wisconsin-Madison, and a BS in Biochemistry from Mount Holyoke College.